Dr. Wahl brings over 15 years of broad legal experience, including significant intellectual property (IP), corporate, and transactional expertise, to the position. In this role, he will provide strategic direction as Tarsus expands its innovative product pipeline, beginning with TP-03 for the potential treatment of Demodex blepharitis.
Dr. Wahl brings over 15 years of broad legal experience, including significant intellectual property (IP), corporate, and transactional expertise, to the position. In this role, he will provide strategic direction as Tarsus expands its innovative product pipeline, beginning with TP-03 for the potential treatment of Demodex blepharitis.